Emerging functions of FMNL1 in myeloid neoplasms: insights from bioinformatics to biological and pharmacological landscapes (2024)
- Authors:
- USP affiliated authors: MACHADO NETO, JOÃO AGOSTINHO - ICB ; VICARI, HUGO PASSOS - ICB ; SILVA, JEAN CARLOS LIPRERI DA - ICB ; CARVALHO, MARIA FERNANDA LOPES - ICB ; LIMA, KELI CRISTINA DE - FM
- Unidades: ICB; FM
- DOI: 10.21037/tcr-24-1091
- Subjects: FARMACOLOGIA; LEUCEMIA MIELOIDE AGUDA; CITOESQUELETO; HEMATOPOESE; EXPRESSÃO GÊNICA; MONÓCITOS; MUTAÇÃO; MICRORNAS; GRANULÓCITOS; BIOINFORMÁTICA
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Source:
- Título: Translational Cancer Research
- ISSN: 2219-6803
- Volume/Número/Paginação/Ano: v. 13, n. 11, p. 6105-6116, 2024
- Este periódico é de acesso aberto
- Este artigo é de acesso aberto
- URL de acesso aberto
- Cor do Acesso Aberto: gold
-
ABNT
VICARI, Hugo Passos et al. Emerging functions of FMNL1 in myeloid neoplasms: insights from bioinformatics to biological and pharmacological landscapes. Translational Cancer Research, v. 13, n. 11, p. 6105-6116, 2024Tradução . . Disponível em: https://dx.doi.org/10.21037/tcr-24-1091. Acesso em: 26 dez. 2025. -
APA
Vicari, H. P., Silva, J. C. L. da, Carvalho, M. F. L., Lima, K., & Machado Neto, J. A. (2024). Emerging functions of FMNL1 in myeloid neoplasms: insights from bioinformatics to biological and pharmacological landscapes. Translational Cancer Research, 13( 11), 6105-6116. doi:10.21037/tcr-24-1091 -
NLM
Vicari HP, Silva JCL da, Carvalho MFL, Lima K, Machado Neto JA. Emerging functions of FMNL1 in myeloid neoplasms: insights from bioinformatics to biological and pharmacological landscapes [Internet]. Translational Cancer Research. 2024 ; 13( 11): 6105-6116.[citado 2025 dez. 26 ] Available from: https://dx.doi.org/10.21037/tcr-24-1091 -
Vancouver
Vicari HP, Silva JCL da, Carvalho MFL, Lima K, Machado Neto JA. Emerging functions of FMNL1 in myeloid neoplasms: insights from bioinformatics to biological and pharmacological landscapes [Internet]. Translational Cancer Research. 2024 ; 13( 11): 6105-6116.[citado 2025 dez. 26 ] Available from: https://dx.doi.org/10.21037/tcr-24-1091 - Transcriptomics analysis identified ezrin as a potential druggable target in cervical and gastric cancer cells
- Ezrin is highly expressed and a druggable target in chronic lymphocytic leukemia
- Obatoclax reduces cell viability of acute myeloid leukemia cell lines independently of their sensitivity to venetoclax
- Comprehensive analysis of the HCK gene in myeloid neoplasms: insights into biological functions, prognosis, and response to antineoplastic agents
- NSC305787, a pharmacological ezrin inhibitor, exhibits antineoplastic activity in pancreatic cancer cells
- Cellular and molecular effects of Eribulin in preclinical models of hematologic neoplasms
- ARHGAP6 transcript levels are associated with molecular risk and impact survival outcomes in acute myeloid leukemia
- CDC7 (cell division cycle 7)
- Synthesis and evaluation of 2-substituted quinazolin-4(3H)-ones as potential antileukemic agents
- Synthetic cyclopenta[b]indoles exhibit antineoplastic activity by targeting microtubule dynamics in acute myeloid leukemia cells
Informações sobre o DOI: 10.21037/tcr-24-1091 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
